These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 35665597)

  • 1. Mechanisms of 8-aminoquinoline induced haemolytic toxicity in a G6PDd humanized mouse model.
    Flaherty S; Strauch P; Maktabi M; Pybus BS; Reichard G; Walker LA; Rochford R
    J Cell Mol Med; 2022 Jul; 26(13):3675-3686. PubMed ID: 35665597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primaquine-induced haemolysis in females heterozygous for G6PD deficiency.
    Chu CS; Bancone G; Nosten F; White NJ; Luzzatto L
    Malar J; 2018 Mar; 17(1):101. PubMed ID: 29499733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling primaquine-induced haemolysis in G6PD deficiency.
    Watson J; Taylor WR; Menard D; Kheng S; White NJ
    Elife; 2017 Feb; 6():. PubMed ID: 28155819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. G6PD deficiency alleles in a malaria-endemic region in the Western Brazilian Amazon.
    Dombrowski JG; Souza RM; Curry J; Hinton L; Silva NRM; Grignard L; Gonçalves LA; Gomes AR; Epiphanio S; Drakeley C; Huggett J; Clark TG; Campino S; Marinho CRF
    Malar J; 2017 Jun; 16(1):253. PubMed ID: 28619120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical complications of G6PD deficiency in Latin American and Caribbean populations: systematic review and implications for malaria elimination programmes.
    Monteiro WM; Franca GP; Melo GC; Queiroz AL; Brito M; Peixoto HM; Oliveira MR; Romero GA; Bassat Q; Lacerda MV
    Malar J; 2014 Feb; 13():70. PubMed ID: 24568147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primaquine in glucose-6-phosphate dehydrogenase deficiency: an adaptive pharmacometric assessment of ascending dose regimens in healthy volunteers.
    Pukrittayakamee S; Jittamala P; Watson JA; Hanboonkunupakarn B; Leungsinsiri P; Poovorawan K; Chotivanich K; Bancone G; Chu CS; Imwong M; Day NPJ; Taylor WRJ; White NJ
    Elife; 2024 Feb; 12():. PubMed ID: 38319064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial.
    St Jean PL; Xue Z; Carter N; Koh GC; Duparc S; Taylor M; Beaumont C; Llanos-Cuentas A; Rueangweerayut R; Krudsood S; Green JA; Rubio JP
    Malar J; 2016 Feb; 15():97. PubMed ID: 26888075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map.
    Howes RE; Piel FB; Patil AP; Nyangiri OA; Gething PW; Dewi M; Hogg MM; Battle KE; Padilla CD; Baird JK; Hay SI
    PLoS Med; 2012; 9(11):e1001339. PubMed ID: 23152723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity.
    Rochford R; Ohrt C; Baresel PC; Campo B; Sampath A; Magill AJ; Tekwani BL; Walker LA
    Proc Natl Acad Sci U S A; 2013 Oct; 110(43):17486-91. PubMed ID: 24101478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tafenoquine for the treatment of
    Llanos-Cuentas A; Manrrique P; Rosas-Aguirre A; Herrera S; Hsiang MS
    Expert Opin Pharmacother; 2022 May; 23(7):759-768. PubMed ID: 35379070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of G6PD status and haemolytic anaemia in patients receiving anti-malarial agents: a systematic review and meta-analysis.
    Nelwan EJ; Shakinah S; Pasaribu A
    Malar J; 2023 Mar; 22(1):77. PubMed ID: 36872344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-Dose Primaquine in a Preclinical Model of Glucose-6-Phosphate Dehydrogenase Deficiency: Implications for Use in Malaria Transmission-Blocking Programs.
    Wickham KS; Baresel PC; Marcsisin SR; Sousa J; Vuong CT; Reichard GA; Campo B; Tekwani BL; Walker LA; Rochford R
    Antimicrob Agents Chemother; 2016 Oct; 60(10):5906-13. PubMed ID: 27458212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tafenoquine for
    Sharma J; Gautam CS; Singh H; Singh J
    Indian J Med Res; 2021 Jun; 154(6):797-805. PubMed ID: 35662084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamics of G6PD activity in patients receiving weekly primaquine for therapy of Plasmodium vivax malaria.
    Taylor WRJ; Kim S; Kheng S; Muth S; Tor P; Christophel E; Mukaka M; Kerleguer A; Luzzatto L; Baird JK; Menard D
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009690. PubMed ID: 34495956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative ophthalmic assessment of patients receiving tafenoquine or chloroquine/primaquine in a randomized clinical trial for Plasmodium vivax malaria radical cure.
    Warrasak S; Euswas A; Fukuda MM; Ittiverakul M; Miller RS; Krudsood S; Ohrt C
    Int Ophthalmol; 2019 Aug; 39(8):1767-1782. PubMed ID: 30269312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. G6PD deficiency in Latin America: systematic review on prevalence and variants.
    Monteiro WM; Val FF; Siqueira AM; Franca GP; Sampaio VS; Melo GC; Almeida AC; Brito MA; Peixoto HM; Fuller D; Bassat Q; Romero GA; Maria Regina F O; Marcus Vinícius G L
    Mem Inst Oswaldo Cruz; 2014 Aug; 109(5):553-68. PubMed ID: 25141282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemolysis in G6PD Heterozygous Females Treated with Primaquine for Plasmodium vivax Malaria: A Nested Cohort in a Trial of Radical Curative Regimens.
    Chu CS; Bancone G; Moore KA; Win HH; Thitipanawan N; Po C; Chowwiwat N; Raksapraidee R; Wilairisak P; Phyo AP; Keereecharoen L; Proux S; Charunwatthana P; Nosten F; White NJ
    PLoS Med; 2017 Feb; 14(2):e1002224. PubMed ID: 28170391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative pharmacokinetics and tissue distribution of primaquine enantiomers in mice.
    Fasinu PS; Chaurasiya ND; Dhammika Nanayakkara NP; Wang YH; Bandara Herath HMT; Avula B; McChesney JD; Jollow D; Walker LA; Tekwani BL
    Malar J; 2022 Feb; 21(1):33. PubMed ID: 35123453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tafenoquine versus Primaquine to Prevent Relapse of Plasmodium vivax Malaria.
    Llanos-Cuentas A; Lacerda MVG; Hien TT; Vélez ID; Namaik-Larp C; Chu CS; Villegas MF; Val F; Monteiro WM; Brito MAM; Costa MRF; Chuquiyauri R; Casapía M; Nguyen CH; Aruachan S; Papwijitsil R; Nosten FH; Bancone G; Angus B; Duparc S; Craig G; Rousell VM; Jones SW; Hardaker E; Clover DD; Kendall L; Mohamed K; Koh GCKW; Wilches VM; Breton JJ; Green JA
    N Engl J Med; 2019 Jan; 380(3):229-241. PubMed ID: 30650326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The reality of using primaquine.
    Burgoine KL; Bancone G; Nosten F
    Malar J; 2010 Dec; 9():376. PubMed ID: 21184691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.